Healthtech firm BeatO raises $5.7-M from W Health Ventures, others

New Delhi-based digital care ecosystem for chronic condition management BeatO has raised USD 5.7 million in funding led by US-based venture capital firm W Health Ventures. The funding also saw participation from e-pharmacy Unicorn PharmEasy (a Threpsi Solutions Pvt Ltd brand), Merisis VP and existing investors Orios VP, Leo Capital, and others. The fresh funds will be utilized across two key areas – growth in subscriber base across multiple channels and geographies, and product enhancement to provide care for other cardiometabolic conditions. BeatO's digital health platform combines real-time monitoring through its IoT-connected devices and app ecosystem to provide AI-driven personalized insights and proactive intervention by doctors and health coaches to patients with chronic conditions.